A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder

NCT04969510 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: 10 mg PRAX-114
DRUG: 20 mg PRAX-114
DRUG: 40 mg PRAX-114
DRUG: 60 mg PRAX-114
DRUG: Placebo

Sponsor

Praxis Precision Medicines